FDA issued a Warning Letter to McGuff Pharmaceuticals Inc. on 12/28/2010 for a previous inspection.
483 McGuff Pharmaceuticals Mar 2017

483 McGuff Pharmaceuticals Mar 2017

$119 - Not in Stock

FDA investigators audited the McGuff Pharmaceuticals - Santa Ana, CA, United States facility and issued inspectional observations (via FDA 483) on 31 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Mar 2017
  • Location: Santa Ana, United States
  • FEI: 2022073
Order